Dr. Neurath studies the immunologic and molecular mechanisms in the pathogenesis of Inflammatory Bowel Disease and gastrointestinal cancer to create new therapeutic options for patients.
The Nice lab studies the biology of the intestinal innate immune cells and cytokines—how they promote intestinal health and resistance to infection. They seek to understand how immune pathways function and become dysfunctional in disease states.
The Nowarski lab studies what makes or breaks tissue inflammation with a focus on cytokine signaling, immunometabolism and innate immune memory.
The Kattah Lab aims to understand how intestinal epithelial cells contribute to disease. The ultimate goal is to develop patient-tailored treatment strategies that maximize efficacy and minimize toxicity for individual patients.
Dr. Kamada’s lab investigates how gut microbiota and host immunity interact in gastrointestinal health and disease. Their focus is on the mechanism by which certain pathogenic members of commensal bacteria promote chronic intestinal inflammation that leads to Inflammatory Bowel Disease.
Dr. Ekici is using the newest technology for high-throughput profiling and data analysis in a broad spectrum of human genetics research.
The Hinterleitner lab is interested in the fascinating yet complex events happening in our intestines every day. They are trying to understand the crosstalk between intestinal microbes, diets and the host mucosal immune system.
By coordinating collaborative multi-disciplinary research efforts and public-private consortium, Dr. Colombel implements major clinical trials that have the potential to significantly improve treatments for patients across the spectrum of IBD.
Dr. Davis’s lab focuses on the mechanical and electrophysiological properties of lymphatic smooth muscle and endothelium and how dysfunction of those cell types contributes to lymphedema.
Dr. Denson’s multi-center research program focuses on discovering underlying mechanisms and better therapeutic approaches in chronic inflammation, growth and mucosal healing related to adult and pediatric patients with IBD.
